isatuximab,carfilzomib,dexamethasone
Sanofi,amgen
['ikema']
further emphasizing the excellent results of the ikema trial. #ash22 
Professor and head of Hematology Sorbonne Univ.; past-president of the EBMT; Chairman of the IACH; Editor in Chief: Bone Marrow Transplant; Clin Hematol Int.